Cargando…
MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy?
IgA nephropathy (IgAN) is the most common cause of primary glomerulonephritis worldwide. Up to 30% of cases develop the progressive form of the disease, eventually requiring renal replacement therapy. Diagnosis and risk stratification relies on an invasive kidney biopsy and management options are li...
Autores principales: | Selvaskandan, Haresh, Pawluczyk, Izabella, Barratt, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798124/ https://www.ncbi.nlm.nih.gov/pubmed/29423198 http://dx.doi.org/10.1093/ckj/sfx096 |
Ejemplares similares
-
The investigative burden of membranous nephropathy in the UK
por: Hamilton, Patrick, et al.
Publicado: (2019) -
The Non-Coding RNA Landscape in IgA Nephropathy—Where Are We in 2021?
por: Pawluczyk, Izabella Z. A., et al.
Publicado: (2021) -
Higher serum galactose-deficient immunoglobulin A1 concentration is associated with stronger mesangial cellular inflammatory response and more severe histologic findings in immunoglobulin A nephropathy
por: Nguyen, Celine, et al.
Publicado: (2018) -
Study protocol: responding to the needs of patients with IgA nephropathy, a social media approach
por: Graham-Brown, Matthew P M, et al.
Publicado: (2018) -
Rituximab-induced serum sickness in the treatment of idiopathic membranous nephropathy
por: Cheong, Jamie, et al.
Publicado: (2018)